Small Cell Lung Cancer

2008/03/01 by Taimur Sher, Grace K. Dy, Alex A. Adjei · 520 citations
Medicine · #Cancer #Chemotherapy #Cisplatin #Colorectal cancer #Combination chemotherapy #Epidermal growth factor receptor #Gefitinib #Internal medicine #Irinotecan #Lung Cancer Research Studies #Lung Cancer Treatments and Mutations #Lung cancer #Medicine #Neuroendocrine Tumor Research Advances #Oncology #Radiation therapy #Regimen #Surgery #Vinorelbine

paper · doi:10.4065/83.3.355

published in Mayo Clinic Proceedings 83(3), 355-367 (Elsevier BV)

openalex publication_date 2008/03/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
• Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
• LIMD1 Loss Confers a GPX4-Dependent Cell State in Lung Cancer
• Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. [europepmc]
• A small-cell lung cancer genome with complex signatures of tobacco exposure. [europepmc]
• MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs. [europepmc]
• Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304). [europepmc]
• NF-κB addiction and its role in cancer: 'one size does not fit all'. [europepmc]
• Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. [europepmc]
• Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer. [europepmc]
• Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens. [europepmc]
• Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer. [europepmc]
• Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer. [europepmc]
• Non-small cell lung cancer: current treatment and future advances. [europepmc]
• Update on large cell neuroendocrine carcinoma. [europepmc]
• Cell death-based treatment of lung adenocarcinoma. [europepmc]
• PRMT7 contributes to the metastasis phenotype in human non-small-cell lung cancer cells possibly through the interaction with HSPA5 and EEF2 . [europepmc]
• Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. [europepmc]
• A novel mutation panel for predicting etoposide resistance in small-cell lung cancer. [europepmc]
• Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes. [europepmc]
• Luteolin attenuates migration and invasion of lung cancer cells via suppressing focal adhesion kinase and non-receptor tyrosine kinase signaling pathway. [europepmc]
• A combined "eat me/don't eat me" strategy based on extracellular vesicles for anticancer nanomedicine. [europepmc]
• Triangular Relationship between p53, Autophagy, and Chemotherapy Resistance. [europepmc]
• Sex and Gender Differences in Lung Disease. [europepmc]
• Role of sex hormones in lung cancer. [europepmc]
• FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma. [europepmc]
• Radiomics in Early Lung Cancer Diagnosis: From Diagnosis to Clinical Decision Support and Education. [europepmc]
• Advances in Lung Cancer Treatment Using Nanomedicines. [europepmc]